NCT05641402 is a NA clinical trial of Text messages in Type 2 Diabetes, sponsored by University of Manchester.

Who is sponsoring NCT05641402?

NCT05641402 is sponsored by University of Manchester.

What drugs are being tested in NCT05641402?

Interventions in NCT05641402: Text messages.

What condition does NCT05641402 study?

NCT05641402 studies Type 2 Diabetes.

Is NCT05641402 still recruiting?

NCT05641402 is currently completed. Last updated 20 January 2025.

Last reviewed 2025-01-20 · How we verify

NCT05641402

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evidence-based Text Messages to Target Diet and Physical Activity

Completed NA Last updated 20 January 2025

What this trial tests

NA trial testing Text messages in Type 2 Diabetes in 148 participants. Completed in 30 June 2024.

Timeline

14 July 2022

Primary endpoint
23 November 2023

30 June 2024

Quick facts

Lead sponsor	University of Manchester
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	148
Start date	14 July 2022
Primary completion	23 November 2023
Estimated completion	30 June 2024
Sites	1 location across United Kingdom

Drugs / interventions tested

Text messages

Conditions studied

Type 2 Diabetes — all drugs for Type 2 Diabetes →

Sponsor

University of Manchester

Who can join

18 and older, any sex, with Type 2 Diabetes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This research aims to develop a bank of text messages based on behaviour change techniques targeting specific diet and physical activity behaviours in people with type 2 diabetes

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Acceptability of text messages to encourage diet and physical activity in people with Type 2 diabetes: Sequential survey and pilot feasibility studies
Simao SC, Musa C, French DP, Miles LM, et al · · 2026 · DOI 10.21203/rs.3.rs-9843451/v1

Verify or expand the search:

Other trials of Text messages

Trials testing the same drug.

NCT07205991 — ADHERE Trial: Strategies to Improve Mobile App Adherence · NA · recruiting
NCT06614361 — Community-based Behavioral Intervention to Increase Vaccination Using MOST · Phase 2 · withdrawn
NCT06181253 — The Impact of Prehabilitation · NA · terminated
NCT04504357 — Integrating U=U Into HIV Counseling in South Africa · NA · completed
NCT04609553 — Literacy Promotion for Latinos Study · NA · completed

Other recruiting trials for Type 2 Diabetes

Currently open trials in the same condition.

NCT07053319 — SGLT2i, Pioglitazone, and Ketone Production in T2D · Phase 1 · recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07463859 — Effects of Periodontal Treatment Associated With Antimicrobial Photodynamic Therapy on Halitosis in Patients With Diabet · NA · recruiting
NCT07254689 — The Food for Health Study · NA · recruiting
NCT07558863 — Effect of GLP-1RA on Cardiac Autonomic Neuropathy in Type 2 Diabetes · Phase 4 · recruiting

Other University of Manchester trials

Trials by the same sponsor.

NCT07506096 — Using IF-THEN Plans to Support Healthcare Professionals in Raising Patient Safety Concerns · NA · not yet recruiting
NCT07084090 — Using IF-THEN Plans to Support Patients in Raising Safety Concerns About Their Care · NA · not yet recruiting
NCT07494760 — A Feasibility Randomised Control Trial to Evaluate Early Perinatal Bereavement Counselling for Parents Who Have Experien · NA · not yet recruiting
NCT07372885 — GRanulocyte Augmented Cord Blood Transplantation for Poor Risk leukaEmia · Phase 1, PHASE2 · not yet recruiting
NCT07381894 — Multicentre Hypertrophic Cardiomyopathy Registry · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05641402 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Manchester
Last refreshed: 20 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05641402.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing